The parachute mitral valve is a rare congenital anomaly in which all the chordae tendineae of the mitral valve insert into a single papillary muscle, rather than into two distinct muscles as in normal cardiac anatomy, giving the valve its characteristic parachute-like appearance. This abnormal arrangement limits leaflet mobility and hinders normal diastolic flow from the left atrium to the left ventricle, resulting in a functional picture of mitral stenosis, often in the absence of intrinsic leaflet abnormalities.
The term “parachute” derives from the morphological appearance of the mitral valve complex, in which the leaflets converge toward a single central point, visually resembling a suspended dome. The severity of the obstruction depends on several factors: the length of the chordae tendineae, the position of the papillary muscle, the size of the mitral orifice, and the presence of associated abnormalities.
This malformation may occur as an isolated entity, but it is more frequently part of complex syndromes involving left heart obstruction, particularly in Shone’s syndrome. Early diagnosis is essential to prevent the development of pulmonary hypertension and progressive heart failure.
The parachute mitral valve results from an anomaly in the development of the papillary muscles during cardiac morphogenesis, specifically during the 4th and 5th weeks of gestation. Under normal conditions, the endocardial cushions and neural crest–derived mesenchyme contribute to the formation of two distinct papillary muscles — anterolateral and posteromedial — which serve as insertion points for the chordae tendineae of the mitral valve leaflets.
In the parachute valve, however, there is a failure of segmentation and migration of the myocardial precursor, leading to the formation of a single, centrally or eccentrically located papillary muscle. All the chordae tendineae converge on this solitary structure, limiting the symmetric opening of the leaflets and causing functional mitral stenosis, even in the absence of commissural fusion or obvious valvular dysplasia.
The condition may be isolated, but is frequently associated with other left heart anomalies, forming part of Shone’s syndrome (a malformation complex including supravalvular mitral ring, aortic coarctation, and subaortic stenosis). In these cases, the valvular anomaly represents only one of several obstructive elements in a hypoplastic or functionally reduced left heart.
Among the known risk factors, familial cases and mutations in genes involved in cardiac morphogenesis (such as GATA4, TBX5, and NKX2-5) have been described, although in most patients the malformation appears as a sporadic event. It is possible that epigenetic errors or early environmental influences contribute to interference with the separation and positioning of the papillary muscles.
The pathogenic mechanism underlying dysfunction is the unilateral traction of the valve leaflets during diastole. The concentric insertion of the chordae on a single muscle prevents wide, coordinated leaflet opening, resulting in a narrowed valvular orifice and turbulent flow from the left atrium to the left ventricle. This leads to a progressive increase in left atrial pressure and pulmonary venous pressures, with early-onset symptoms of pulmonary congestion.
Over time, chronic obstruction to ventricular filling may induce compensatory left ventricular hypertrophy, especially in the presence of associated lesions. The reduction in ventricular compliance further impairs diastolic filling and leads to a progressive rise in filling pressures, with eventual compromise of global ventricular performance.
In some cases, the asymmetric traction exerted by the chordae tendineae may also impair systolic coaptation, favoring the development of secondary mitral regurgitation. When pressure overload and ventricular remodeling are not promptly corrected, irreversible hemodynamic dysfunction and the risk of arrhythmias may arise, especially in older patients.
The clinical manifestations of the parachute mitral valve vary according to the degree of mitral obstruction, the presence of associated lesions, and the compensatory capacity of the left heart. Mild forms may remain silent for years, whereas severe cases present within the first days or weeks of life with signs of heart failure.
In symptomatic neonates, the clinical picture reflects a pressure overload of the left atrium and increased pulmonary pressures.
The most frequent symptoms include:
In this phase, the presentation may mimic other forms of congenital mitral stenosis. Diagnosis is often made only after echocardiography is performed in response to clinical suspicion of heart disease.
In older children, the main symptom is often exertional dyspnea, accompanied by early fatigability, palpitations, or poor performance during physical activities. In the absence of overt signs, the malformation may be discovered incidentally during evaluation for a murmur or ECG abnormalities.
During adolescence, the hemodynamic consequences of the valve become more pronounced. Left atrial dilation predisposes to supraventricular arrhythmias such as atrial tachycardia or atrial fibrillation, which may occur even in seemingly well-compensated individuals.
On physical examination, typical findings include a diastolic murmur at the apex, which may be difficult to detect in neonates, and an accentuated second heart sound in the presence of pulmonary hypertension. In older children, a broad or irregular apical impulse may be observed, indicating left ventricular overload.
In patients with Shone’s syndrome, the parachute valve is associated with other forms of left heart obstruction, and the clinical picture reflects the cumulative effect of these abnormalities. The concomitant presence of aortic coarctation or subaortic stenosis may lead to earlier symptom onset or more severe presentations.
If secondary mitral regurgitation develops, the clinical picture may evolve toward signs of volume overload, with worsening exercise tolerance and progressive atrial dilation. Even in asymptomatic individuals, careful follow-up is essential to detect early disease progression and prevent long-term complications.
The diagnosis of a parachute mitral valve requires a combination of clinical suspicion, targeted physical examination, and high-resolution echocardiographic imaging. The anomaly is suspected in neonates and infants presenting with signs of left heart failure in the absence of evident valvular dysplasia, or in older children with reduced exercise tolerance and apical diastolic murmurs. In many cases, however, it is discovered incidentally during evaluation for heart murmurs or ECG anomalies.
Transthoracic echocardiography is the first-line investigation and allows diagnosis in most cases. The hallmark finding is the insertion of all chordae tendineae into a single papillary muscle, usually located in the inferomedial wall of the left ventricle. This feature may be harder to identify in neonates or in patients with limited acoustic windows, but the orientation of the chordae and the appearance of the mitral orifice help differentiate this malformation from other valvular stenoses.
Continuous-wave Doppler enables quantification of the transvalvular gradient, which can vary widely depending on chordal length and tension. A mean gradient ≥ 5 mmHg suggests significant obstruction, but must be interpreted in the context of left ventricular size and systemic output. In cases with multiple associated lesions, as in Shone’s syndrome, the gradient may be masked by upstream or downstream obstructions.
The mitral diastolic flow typically appears slowed, with aliasing and sometimes with prolonged deceleration time. Assessment of ventricular function, atrial filling, and pulmonary systolic pressure are essential components for risk stratification and therapeutic planning.
Transesophageal echocardiography is indicated in patients with inadequate transthoracic windows or when the anatomical definition is insufficient for surgical planning. It provides a more precise view of the valve plane, leaflets, chordae, and papillary muscles, allowing differentiation of pure forms from “near-parachute” variants, in which both papillary muscles are present but abnormally close together.
Cardiac magnetic resonance imaging (MRI) is indicated in older children or in patients with complex anatomical anomalies. It provides critical information on left heart anatomy, ventricular mass and function, and atrial dimensions. It is particularly useful in the follow-up of patients after corrective surgery, as it allows monitoring of global function and early detection of diastolic dysfunction or progressive dilation.
Cardiac catheterization is reserved for selected situations: when there is a discrepancy between clinical and echocardiographic findings, in cases of left ventricular hypoplasia, or when a complete preoperative hemodynamic assessment is required. It allows direct measurement of atrial pressures, transvalvular gradients, cardiac output, and pulmonary vascular resistance.
The differential diagnosis includes congenital mitral stenosis due to dysplastic valves, supravalvular mitral ring, and double-orifice mitral valve. In some cases, multiple anomalies coexist within the mitral complex, so the echocardiographer must carefully assess chordal arrangement, leaflet coaptation, and the overall geometry of the left ventricle.
Early and accurate diagnosis is critical for establishing a structured follow-up and, when appropriate, planning surgical intervention before the onset of fixed pulmonary hypertension or irreversible ventricular dysfunction. In asymptomatic patients, anatomical definition allows distinguishing progressive forms from those amenable to long-term monitoring alone.
The therapeutic management of parachute mitral valve depends on several factors: degree of mitral obstruction, presence of clinical symptoms, left ventricular function, and any associated anomalies. Mild or hemodynamically insignificant forms do not require immediate treatment but should be monitored over time to detect early signs of progression.
In symptomatic patients or those with a significant transvalvular gradient, treatment is surgical and aims to remove the functional obstruction to diastolic flow.
Surgery is indicated in the presence of:
The surgical approach varies according to valve morphology and obstruction severity. The main goal is to restore adequate diastolic flow through the mitral valve, while preserving the native anatomy as much as possible. When all chordae tendineae insert on a single papillary muscle, as in the classic form of parachute valve, surgical relocation or remodeling of the chordae can be performed to redistribute tension and improve leaflet opening.
In cases where the valvular apparatus shows significant dysplasia, mitral annular hypoplasia, or anatomical limitations that prevent effective repair, a more extensive mitral valve repair or, as a last resort, valve replacement with a mechanical or biological prosthesis may be required. In pediatric patients, valve replacement is reserved only when repair is not technically feasible, to avoid complications related to chronic anticoagulation and the lack of prosthetic growth with the child.
Surgical strategies can be classified into three main types:
The decision between repair and replacement depends on multiple factors, including patient age, tissue quality, and associated lesions. When possible, valve repair is preferred to preserve the anatomical structure and promote better postoperative ventricular remodeling. In pediatric patients, mechanical prosthesis replacement entails lifelong anticoagulation and, in the case of bioprostheses, the risk of early degeneration.
In patients with Shone’s syndrome or complex left heart anomalies, mitral surgery must be part of a combined intervention, which may include aortic coarctation repair, resection of supravalvular rings, or subaortic plastic surgery. In such cases, the therapeutic strategy is defined at advanced pediatric cardiac centers and tailored to the overall hemodynamic balance.
Prognosis depends on the timing of diagnosis and the ability to achieve complete anatomical correction. In isolated forms treated early, the outcome is generally favorable, with regression of symptoms, normalization of pulmonary pressures, and recovery of diastolic function. However, patients must be followed over time to detect:
Follow-up includes periodic cardiology evaluations, serial echocardiograms, and functional assessment with stress testing or MRI in complex cases. Patients with valve prostheses require specific monitoring of anticoagulation and surveillance for thrombotic or infectious complications.
Timely diagnosis, appropriate surgical planning, and rigorous follow-up are key to ensuring a good quality of life and preventing long-term complications.
Complications of parachute mitral valve depend on the initial severity of obstruction and the timeliness and quality of surgical treatment. In untreated or late-managed patients, the primary evolution is toward chronic pulmonary hypertension secondary to persistent left atrial pressure overload. This condition may become irreversible if surgery is not performed early.
Another significant complication is left ventricular dysfunction due to chronic diastolic filling impairment. When mitral obstruction leads to hypertrophy and loss of compliance, the left ventricle may develop a restrictive cardiomyopathy pattern with reduced functional reserve, even after anatomical correction.
In surgically treated patients, the most common complication is postoperative mitral regurgitation, which may result from residual abnormal traction, incomplete leaflet coaptation, or intraoperative damage to the chordae. In severe cases, early reoperation or eventual definitive valve replacement may be required.
Post-surgical restenosis of the mitral valve is less frequent but can occur in the presence of residual fibrous tissue, marked valvular hypoplasia, or asymmetric growth of the mitral complex. Regular echocardiographic monitoring is essential to detect new restrictions to flow.
Patients operated on at older ages or with significant pre-existing atrial dilation may develop supraventricular arrhythmias, particularly atrial fibrillation or ectopic atrial tachycardias. These conditions may worsen pulmonary congestion and require pharmacologic or ablative treatment.
Another typical complication of complex syndromic forms is the progression of associated obstructive lesions, such as aortic coarctation or subaortic stenosis. In these cases, even optimal mitral correction may not be sufficient to maintain stable hemodynamic balance, necessitating additional surgical interventions.
Finally, in patients with mechanical valve replacement, long-term risks related to chronic anticoagulant therapy must be considered, including bleeding, valve thrombosis, and infective endocarditis. Carriers of bioprosthetic valves, on the other hand, face the possibility of structural degeneration requiring reoperation after several years.
A multidisciplinary approach and dedicated cardiology follow-up are essential to monitor clinical evolution, detect early signs of decompensation or valve dysfunction, and plan additional therapeutic strategies over the long term.